Where Will IonQ Stock Be in 1 Year?

The market is likely to overread the revenue math and underweight revenue quality. Adding low-margin foundry revenue can make the top line look optically cheaper, but it does little for per-share value if the acquired business drags gross margin, consumes management bandwidth, and is funded with stock at a premium valuation. In the next 1-3 months, the stock is more likely to trade on whether the combined company can show cleaner unit economics and slower dilution than on any headline revenue reset.

The second-order winner is the more “pure” quantum story: names like QUBT can benefit if investors decide IonQ is morphing into a roll-up rather than a focused technology winner. That relative-scarcity premium matters because capital is likely to rotate toward whichever company can show the cleanest path from research spend to commercial revenue without an acquisition overhang. The loser is any investor who assumes scale alone will compress the multiple; in this part of the market, the denominator expansion does not matter much if the numerator stays negative.

The key risk is that management uses acquisitions to buy time rather than solve the core profitability problem. If the next combined-quarter print shows continued SBC growth, weak cash conversion, or no evidence that SkyWater is accretive to gross profit, the stock can de-rate back toward the low-30s even if reported revenue stays elevated. Conversely, a sustained move above the post-deal highs would require proof that integration is not just accounting accretion but real margin expansion; absent that, this looks like a fade, not a breakout.